As of 2024-12-12, the Intrinsic Value of Genflow Biosciences PLC (GENF.L) is
-2.19 GBP. This GENF.L valuation is based on the model Peter Lynch Fair Value.
With the current market price of 1.62 GBP, the upside of Genflow Biosciences PLC is
-234.74%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
-2.19 GBP
Intrinsic Value
GENF.L Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| Fair Value |
-2.19 - -2.19 |
-2.19 |
-234.74% |
| DDM - Stable |
(1.79) - (3.58) |
(2.68) |
-265.2% |
| DDM - Multi |
(1.23) - (1.96) |
(1.52) |
-193.5% |
GENF.L Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
5.68 |
| Beta |
-1.47 |
| Outstanding shares (mil) |
3.50 |
| Enterprise Value (mil) |
4.54 |
| Market risk premium |
5.98% |
| Cost of Equity |
18.07% |
| Cost of Debt |
5.00% |
| WACC |
11.06% |